Year: 2020
Type: review
Abstract: Natural products account for more than 50% of all small-molecule pharmaceutical agents currently in clinical use. However, low availability often becomes problematic when a bioactive natural product is promising to become a pharmaceutical or leading compound. Advances in synthetic biology and metabolic engineering provide a feasible solution for sustainable supply of these compounds. In this review, we have summarized current progress in engineering yeast cell factories for production of natural products, including terpenoids, alkaloids, and phenylpropanoids. We then discuss advanced strategies in metabolic engineering at three different dimensions, including point, line, and plane (corresponding to the individual enzymes and cofactors, metabolic pathways, and the global cellular network). In particular, we comprehensively discuss how to engineer cofactor biosynthesis for enhancing the biosynthesis efficiency, other than the enzyme activity. Finally, current challenges and perspective are also discussed for future engineering direction.
Source: iScience
Authors: Ruibing Chen, Shan Yang, Lei Zhang, Yongjin J. Zhou
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,000
Funders: National Natural Science Foundation of China, Liaoning Revitalization Talents Program, Dalian Institute of Chemical Physics, National Key Research and Development Program of China, Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences, National Key Research and Development Program of China Stem Cell and Translational Research
OpenAlex ID: W3003633836
